Biodefense Squeezes US Science Budgets

Francesco FiondellaWhen he addressed the nation in January, President George W. Bush left little doubt that he intends to invest enormous amounts of federal cash into homeland security, including efforts to protect Americans from bioterrorism. What the president did not say during his annual State of the Union speech was where the funds will come from.The federal budgets for FY2004 and FY2005 reflect a fundamental shift in White House priorities when it comes to scientific research, one that foc

Written byDana Wilkie
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Francesco Fiondella

When he addressed the nation in January, President George W. Bush left little doubt that he intends to invest enormous amounts of federal cash into homeland security, including efforts to protect Americans from bioterrorism. What the president did not say during his annual State of the Union speech was where the funds will come from.

The federal budgets for FY2004 and FY2005 reflect a fundamental shift in White House priorities when it comes to scientific research, one that focuses on homeland security to the detriment of basic biomedical research for some of the world's deadliest diseases, critics say. "After a period of vigorous funding for the National Institutes of Health, the fear is that suddenly the tap is going to be shut off," says Sean Tipton, spokesman for the American Society for Reproductive Medicine. "The problem with science is that it's really difficult to operate in this on-again, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies